U.S. market Closed. Opens in 1 day 2 hours 1 minute

ACOR | Acorda Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue117.63M118.57M129.07M152.97M192.41M
Cost of Revenue46.05M30.33M40.79M33.51M34.85M
Gross Profit71.59M88.23M88.28M119.45M157.56M
Operating Expenses94.85M130.27M165.58M206.35M278.56M
Selling, General & Admin89.70M106.26M124.40M152.58M192.84M
Research & Development5.15M5.80M10.42M23.01M60.08M
Other Operating Expenses51.00K18.21M30.76M30.76M25.64M
Operating Income-23.26M-42.04M-77.30M-86.90M14.55M
Other Expenses / Income-272.76M6.54M-15.15M-1.46M-157.64M
Before Tax Income-296.02M-35.25M-109.07M-107.67M-274.25M
Income Tax Expenses-43.17M30.67M-5.12M-8.07M-1.28M
Net Income-252.85M-65.92M-103.95M-99.59M-272.96M
Interest Expenses31.53M28.29M30.04M30.57M21.87M
Basic Shares Outstanding1.24M985.35K531.05K404.20K395.93K
Diluted Shares Outstanding1.24M985.35K531.05K404.20K395.93K
EBITDA8.40M-10.03M-44.80M-64.95M40.18M
EBITDA Margin7.14%-8.46%-34.71%-42.46%20.88%
EBIT-264.49M-6.96M-79.04M-77.09M-252.38M
EBIT Margin-224.84%-5.87%-61.24%-50.40%-131.17%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙